Search clinical trials for: Exemestane
Total 265 results
-
Actavis Inc.Withdrawn
-
Jules Bordet InstituteNovartisCompleted
-
PfizerTerminated
-
PfizerCompletedPost Menopausal Women With Early Breast Cancer
-
Bristol-Myers SquibbCompletedBreast CancerCzech Republic, United States, Spain, United Kingdom, Ireland, Poland, France, Sweden
-
Veru Inc.WithdrawnMetastatic Breast CancerUnited States
-
Dalin Tzu Chi General HospitalCompletedHearing ImpairmentTaiwan
-
NCIC Clinical Trials GroupUNICANCER; Grupo Espanol de Investigacion del Cancer de MamaCompletedBreast CancerUnited States, France, Canada, Puerto Rico
-
PfizerCompleted
-
Roxane LaboratoriesCompleted
-
PfizerTerminated
-
PfizerCompletedBreast NeoplasmsChina
-
Roxane LaboratoriesCompletedBreast CancerUnited States
-
GlaxoSmithKlineWithdrawnHormone-receptor Positive Breast CancerUnited States
-
PfizerCompletedBreast NeoplasmsFrance
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States
-
NCIC Clinical Trials GroupCompletedBreast CancerUnited States, Canada
-
Roxane LaboratoriesCompleted
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Unknown
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
PfizerTerminatedBreast NeoplasmsUnited Kingdom
-
PfizerCompletedBreast CancerKorea, Republic of
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Puerto Rico
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
Hellenic Breast Surgeons SocietyTerminated
-
PfizerCompleted
-
Centre Leon BerardRecruitingLow Grade Endometrial Stromal SarcomaFrance
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaboratorsCompleted
-
National Cancer Institute, NaplesWithdrawn
-
Northwestern UniversityNational Cancer Institute (NCI)Withdrawn
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
Chipscreen Biosciences, Ltd.Completed
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage I Breast CancerUnited States, Canada, Hong Kong
-
Novartis Healthcare A/SCompleted
-
PfizerTerminatedBreast NeoplasmsUnited States, Canada, Netherlands, Brazil, Belgium, United Kingdom, Argentina, Italy, Sweden
-
Fudan UniversityUnknown
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Institute of Cancer Research, United KingdomUnknown
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
University of Michigan Rogel Cancer CenterDamon Runyon Cancer Research FoundationCompletedPain | Breast Cancer | ArthralgiaUnited States
-
Shanghai Jiao Tong University School of MedicineCompleted
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted